| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'MY' found in 3 terms [] and 45 definitions []
| previous 21 - 25 (of 48) nextResult Pages : [1] [2 3 4 5 6 7 8 9 10] | | | | Searchterm 'MY' was also found in the following services: | | | | |
| | |
| |
|
Coherent gradient echo sequences can measure the free induction decay ( FID), generated just after each excitation pulse or the echo formed prior to the next pulse. Coherent gradient echo sequences are very sensitive to magnetic field inhomogeneity.
An alternative to spoiling is to incorporate residual transverse magnetization directly into the longitudinal steady state.
These GRE sequences use a refocusing gradient in the phase encoding direction during the end module to maximize remaining transverse (xy) magnetization at the time when the next excitation is due, while the other two gradients are, in any case, balanced.
When the next excitation pulse is sent into the system with an opposed phase, it tilts the magnetization in the - a direction. As a result the z-magnetization is again partly tilted into the xy-plane, while the remaining xy-magnetization is tilted partly into the z-direction.
A fully refocused sequence with a properly selected and uniform f would yield higher signal, especially for tissues with long T2 relaxation times (high water content) so it is used in angiographic, myelographic or arthrographic examinations and is used for T2* weighting.
The repetition time for this sequence has to be short. With short TR, coherent GE is also useable for breath hold and 3D technique. If the repetition time is about 200 msec there's no difference between spoiled or unspoiled GE. T1 weighting is better with spoiled techniques.
The common types include GRASS, FISP, FAST, and FFE.
The T2* component decreases with long TR and short TE. The T1 time is controlled by flip angle. The common TR is less than 50 ms and the common TE less than 15 ms
Other types have stronger T2 dependence but lower SNR. They include SSFP, CE-FAST, PSIF, and CE-FFE-T2.
Examples of fully refocused FID sequences are TrueFISP, bFFE and bTFE. | | | | | | | | | |
| | | Searchterm 'MY' was also found in the following services: | | | | |
| | |
| |
|
Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
•
Negative contrast agents (appearing predominantly dark on MRI) are small particulate aggregates often termed superparamagnetic iron oxide ( SPIO). These agents produce predominantly spin spin relaxation effects (local field inhomogeneities), which results in shorter T1 and T2 relaxation times.
SPIO's and ultrasmall superparamagnetic iron oxides ( USPIO) usually consist of a crystalline iron oxide core containing thousands of iron atoms and a shell of polymer, dextran, polyethyleneglycol, and produce very high T2 relaxivities. USPIOs smaller than 300 nm cause a substantial T1 relaxation. T2 weighted effects are predominant.
•
A special group of negative contrast agents (appearing dark on MRI) are perfluorocarbons ( perfluorochemicals), because their presence excludes the hydrogen atoms responsible for the signal in MR imaging.
The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide ( USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.
See also Adverse Reaction and Nephrogenic Systemic Fibrosis.
See also the related poll result: ' The development of contrast agents in MRI is' | | | | | | | | | | | • View the DATABASE results for 'Contrast Agents' (122).
| | | • View the NEWS results for 'Contrast Agents' (25).
| | | | Further Reading: | | Basics:
|
|
News & More:
| |
Brain imaging method may aid mild traumatic brain injury diagnosis Tuesday, 16 January 2024 by parkinsonsnewstoday.com | | |
A Targeted Multi-Crystalline Manganese Oxide as a Tumor-Selective Nano-Sized MRI Contrast Agent for Early and Accurate Diagnosis of Tumors Thursday, 18 January 2024 by www.dovepress.com | | |
FDA Approves Gadopiclenol for Contrast-Enhanced Magnetic Resonance Imaging Tuesday, 27 September 2022 by www.pharmacytimes.com | | |
How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol Saturday, 5 February 2022 by www.ncbi.nlm.nih.gov | | |
Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles Tuesday, 11 January 2022 by pubmed.ncbi.nlm.nih.gov | | |
Manganese enhanced MRI provides more accurate details of heart function after a heart attack Tuesday, 11 May 2021 by www.news-medical.net | | |
Gadopiclenol: positive results for Phase III clinical trials Monday, 29 March 2021 by www.pharmiweb.co | | |
Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series Friday, 4 December 2020 by www.dovepress.com | | |
Polysaccharide-Core Contrast Agent as Gadolinium Alternative for Vascular MR Monday, 8 March 2021 by www.diagnosticimaging.com | | |
Water-based non-toxic MRI contrast agents Monday, 11 May 2020 by chemistrycommunity.nature.com | | |
New method to detect early-stage cancer identified by Georgia State, Emory research team Friday, 7 February 2020 by www.eurekalert.org | | |
Researchers Brighten Path for Creating New Type of MRI Contrast Agent Friday, 7 February 2020 by www.newswise.com | | |
Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents Wednesday, 15 November 2017 by www.eurekalert.org | | |
Sodium MRI May Show Biomarker for Migraine Friday, 1 December 2017 by psychcentral.com | | |
A natural boost for MRI scans Monday, 21 October 2013 by www.eurekalert.org | | |
For MRI, time is of the essence A new generation of contrast agents could make for faster and more accurate imaging Tuesday, 28 June 2011 by scienceline.org |
|
| |
| | | | | |
| |
|
Contrast enhanced MRI is a commonly used procedure in magnetic resonance imaging. The need to more accurately characterize different types of lesions and to detect all malignant lesions is the main reason for the use of intravenous contrast agents.
Some methods are available to improve the contrast of different tissues. The focus of dynamic contrast enhanced MRI (DCE-MRI) is on contrast kinetics with demands for spatial resolution dependent on the application. DCE- MR imaging is used for diagnosis of cancer (see also liver imaging, abdominal imaging, breast MRI, dynamic scanning) as well as for diagnosis of cardiac infarction (see perfusion imaging, cardiac MRI). Quantitative DCE-MRI requires special data acquisition techniques and analysis software.
Contrast enhanced magnetic resonance angiography (CE-MRA) allows the visualization of vessels and the temporal resolution provides a separation of arteries and veins. These methods share the need for acquisition methods with high temporal and spatial resolution.
Double contrast administration (combined contrast enhanced (CCE) MRI) uses two contrast agents with complementary mechanisms e.g., superparamagnetic iron oxide to darken the background liver and gadolinium to brighten the vessels. A variety of different categories of contrast agents are currently available for clinical use.
Reasons for the use of contrast agents in MRI scans are:
•
Relaxation characteristics of normal and pathologic tissues are not always different enough to produce obvious differences in signal intensity.
•
Pathology that is sometimes occult on unenhanced images becomes obvious in the presence of contrast.
•
Enhancement significantly increases MRI sensitivity.
•
In addition to improving delineation between normal and abnormal tissues, the pattern of contrast enhancement can improve diagnostic specificity by facilitating characterization of the lesion(s) in question.
•
Contrast can yield physiologic and functional information in addition to lesion delineation.
Common Indications:
Brain MRI : Preoperative/pretreatment evaluation and postoperative evaluation of brain tumor therapy, CNS infections, noninfectious inflammatory disease and meningeal disease.
Spine MRI : Infection/inflammatory disease, primary tumors, drop metastases, initial evaluation of syrinx, postoperative evaluation of the lumbar spine: disk vs. scar.
Breast MRI : Detection of breast cancer in case of dense breasts, implants, malignant lymph nodes, or scarring after treatment for breast cancer, diagnosis of a suspicious breast lesion in order to avoid biopsy.
For Ultrasound Imaging (USI) see Contrast Enhanced Ultrasound at Medical-Ultrasound-Imaging.com.
See also Blood Pool Agents, Myocardial Late Enhancement, Cardiovascular Imaging, Contrast Enhanced MR Venography, Contrast Resolution, Dynamic Scanning, Lung Imaging, Hepatobiliary Contrast Agents, Contrast Medium and MRI Guided Biopsy. | | | | | | | | | | | • View the DATABASE results for 'Contrast Enhanced MRI' (14).
| | | • View the NEWS results for 'Contrast Enhanced MRI' (8).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
FDA Approves Gadopiclenol for Contrast-Enhanced Magnetic Resonance Imaging Tuesday, 27 September 2022 by www.pharmacytimes.com | | |
Effect of gadolinium-based contrast agent on breast diffusion-tensor imaging Thursday, 6 August 2020 by www.eurekalert.org | | |
Artificial Intelligence Processes Provide Solutions to Gadolinium Retention Concerns Thursday, 30 January 2020 by www.itnonline.com | | |
Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis Tuesday, 12 March 2019 by pubs.rsna.org | | |
The Effects of Breathing Motion on DCE-MRI Images: Phantom Studies Simulating Respiratory Motion to Compare CAIPIRINHA-VIBE, Radial-VIBE, and Conventional VIBE Tuesday, 7 February 2017 by www.kjronline.org | | |
Novel Imaging Technique Improves Prostate Cancer Detection Tuesday, 6 January 2015 by health.ucsd.edu | | |
New oxygen-enhanced MRI scan 'helps identify most dangerous tumours' Thursday, 10 December 2015 by www.dailymail.co.uk | | |
All-organic MRI Contrast Agent Tested In Mice Monday, 24 September 2012 by cen.acs.org | | |
A groundbreaking new graphene-based MRI contrast agent Friday, 8 June 2012 by www.nanowerk.com |
|
| |
| | | Searchterm 'MY' was also found in the following services: | | | | |
| | |
| |
|
| | | | • View the DATABASE results for 'Coronary Angiography with D-Tagging' (3).
| | | | |
| | | Searchterm 'MY' was also found in the following services: | | | | |
| | |
| |
|
(DANTE) A technique used to place a saturation band over e.g. the myocardium. This technique includes spatial modulation of magnetization complementary and delays alternating with nutations for tailored excitation, followed by the application of a cine or real-time imaging. Because the saturated magnetization pattern moves with the atoms of the tissue, the cardiac motion shows up as deformations in the grid pattern in the resulting imaging sequence. | | | | | |
| | | | |
| | | |
|
| |
| Look Ups |
| |